Annexon Bioscience's Incubator/Accelerator Round

Annexon Bioscience raised a round of funding on April 22, 2015. Investors include JLabs.

Annexon Bioscience is developing therapeutics for neurodegenerative and autoimmune disorders. Specifically, the company is working to develop a pipeline of classical complement pathway inhibitors that…

Articles about Annexon Bioscience's Incubator/Accelerator Round: